Firan Technology Group Corporation Announces Acceptance by TSX of Normal Course Issuer Bid Renewal

Stock Information for Crescita Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Crescita Therapeutics Inc.

Firan Technology Group Corporation ("FTG") Announces Third Quarter 2025 Financial Results
2025 Cantech Investment Conference Announces Presenting Companies and Exclusive Networking Events
Firan Technology Group Corporation ("FTG") Announces Third Quarter 2025 Earnings Release and Conference Call Dates
Firan Technology Group Achieves Another Major Milestone with EASA Certification for Edge+ on Airbus A319/320/321 Family of Aircraft
Firan Technology Group Corporation ("FTG") Announces Second Quarter 2025 Financial Results
Firan Technology Group Corporation ("FTG") Announces Second Quarter 2025 Earnings Release and Conference Call Dates
Firan Technology Group Achieves Major Milestone with TCCA Certification for Edge+ on Boeing 737NG Family
Firan Technology Group Corporation Announces Results of AGM

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.